Drug Profile
Artesunate rectal - Cipla/Medicines for Malaria Venture/Strides Pharma Science
Latest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator World Health Organization
- Class 3-ring heterocyclic compounds; Antimalarials; Artemisinins; Small molecules; Succinates
- Mechanism of Action Free radical stimulants; Sarcoplasmic reticulum calcium-transporting ATPase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Malaria in Bangladesh (Rectal, Suppository)
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Malaria in Ghana (Rectal, Suppository)
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Malaria in Tanzania (Rectal, Suppository)